REMSleep Holdings, Inc. (RMSL)
USD 0.01
(-6.25%)
USD 0.01
(-6.25%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.01 Million USD | -21.34% |
| 2022 | 1.29 Million USD | 203.08% |
| 2021 | 425.68 Thousand USD | -9.4% |
| 2020 | 469.84 Thousand USD | -79.94% |
| 2019 | 2.34 Million USD | 695.56% |
| 2018 | 294.38 Thousand USD | -54.81% |
| 2017 | 651.46 Thousand USD | 230.54% |
| 2016 | 197.09 Thousand USD | 128.19% |
| 2015 | 86.37 Thousand USD | -77.85% |
| 2014 | 389.98 Thousand USD | -73.44% |
| 2013 | 1.46 Million USD | 4.59% |
| 2012 | 1.4 Million USD | 1165.7% |
| 2011 | 110.91 Thousand USD | -84.77% |
| 2010 | 728.05 Thousand USD | 2954.57% |
| 2009 | 23.83 Thousand USD | -27.94% |
| 2008 | 33.07 Thousand USD | -12.49% |
| 2007 | 37.79 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 140.94 Thousand USD | -49.4% |
| 2024 Q2 | 292.43 Thousand USD | 125.99% |
| 2023 Q3 | 273.33 Thousand USD | 18.85% |
| 2023 FY | 1.01 Million USD | -21.34% |
| 2023 Q4 | 278.52 Thousand USD | 1.9% |
| 2023 Q1 | 233.05 Thousand USD | -42.2% |
| 2023 Q2 | 229.98 Thousand USD | -1.32% |
| 2022 Q1 | 154.55 Thousand USD | 35.01% |
| 2022 FY | 1.29 Million USD | 203.08% |
| 2022 Q4 | 403.23 Thousand USD | 12.69% |
| 2022 Q3 | 357.82 Thousand USD | -4.47% |
| 2022 Q2 | 374.55 Thousand USD | 142.34% |
| 2021 Q1 | 94.26 Thousand USD | -56.73% |
| 2021 Q3 | 81.86 Thousand USD | -39.4% |
| 2021 Q4 | 114.47 Thousand USD | 39.84% |
| 2021 FY | 425.68 Thousand USD | -9.4% |
| 2021 Q2 | 135.08 Thousand USD | 43.31% |
| 2020 FY | 469.84 Thousand USD | -79.94% |
| 2020 Q1 | 79.39 Thousand USD | -12.08% |
| 2020 Q2 | 114.47 Thousand USD | 44.19% |
| 2020 Q3 | 58.1 Thousand USD | -49.24% |
| 2020 Q4 | 217.87 Thousand USD | 274.95% |
| 2019 FY | 2.34 Million USD | 695.56% |
| 2019 Q4 | 90.29 Thousand USD | -19.69% |
| 2019 Q3 | 112.44 Thousand USD | -94.62% |
| 2019 Q1 | 49.86 Thousand USD | 112.46% |
| 2019 Q2 | 2.08 Million USD | 4089.74% |
| 2018 Q3 | 242.93 Thousand USD | -20.86% |
| 2018 Q2 | 306.99 Thousand USD | 112.29% |
| 2018 Q1 | 144.61 Thousand USD | -67.86% |
| 2018 FY | 294.38 Thousand USD | -54.81% |
| 2018 Q4 | -400.15 Thousand USD | -264.72% |
| 2017 Q4 | 450 Thousand USD | 839.41% |
| 2017 Q3 | 47.9 Thousand USD | -87.69% |
| 2017 Q2 | 389.06 Thousand USD | -6.17% |
| 2017 Q1 | 414.66 Thousand USD | 147.85% |
| 2017 FY | 651.46 Thousand USD | 230.54% |
| 2016 Q4 | 167.3 Thousand USD | 69321.16% |
| 2016 Q1 | 26.26 Thousand USD | 12.38% |
| 2016 Q2 | 3230.00 USD | -87.7% |
| 2016 Q3 | 241.00 USD | -92.54% |
| 2016 FY | 197.09 Thousand USD | 128.19% |
| 2015 Q1 | 24.16 Thousand USD | 5979.08% |
| 2015 FY | 86.37 Thousand USD | -77.85% |
| 2015 Q4 | 23.36 Thousand USD | 10059.57% |
| 2015 Q3 | 230.00 USD | -99.4% |
| 2015 Q2 | 38.61 Thousand USD | 59.8% |
| 2014 FY | 389.98 Thousand USD | -73.44% |
| 2014 Q4 | -411.00 USD | -100.4% |
| 2014 Q3 | 102.3 Thousand USD | -0.01% |
| 2014 Q2 | 102.31 Thousand USD | -44.93% |
| 2014 Q1 | 185.78 Thousand USD | -78.03% |
| 2013 FY | 1.46 Million USD | 4.59% |
| 2013 Q1 | 206.28 Thousand USD | -83.42% |
| 2013 Q2 | 798.38 Thousand USD | 287.03% |
| 2013 Q3 | 202.06 Thousand USD | -74.69% |
| 2013 Q4 | 845.62 Thousand USD | 318.48% |
| 2012 Q4 | 1.24 Million USD | 2173.43% |
| 2012 FY | 1.4 Million USD | 1165.7% |
| 2012 Q1 | 17.25 Thousand USD | -23.86% |
| 2012 Q2 | 45.02 Thousand USD | 160.96% |
| 2012 Q3 | 54.72 Thousand USD | 21.53% |
| 2011 FY | 110.91 Thousand USD | -84.77% |
| 2011 Q3 | - USD | -100.0% |
| 2011 Q2 | 69.18 Thousand USD | 262.98% |
| 2011 Q1 | 19.06 Thousand USD | -89.63% |
| 2011 Q4 | 22.66 Thousand USD | 0.0% |
| 2010 Q4 | 183.79 Thousand USD | -44.57% |
| 2010 Q3 | 331.56 Thousand USD | 55.88% |
| 2010 Q2 | 212.69 Thousand USD | 6599.18% |
| 2010 Q1 | 3175.00 USD | 638.14% |
| 2010 FY | 728.05 Thousand USD | 2954.57% |
| 2009 Q1 | 12.9 Thousand USD | 282.98% |
| 2009 Q2 | 11.32 Thousand USD | -12.21% |
| 2009 Q4 | -590.00 USD | -395.0% |
| 2009 Q3 | 200.00 USD | -98.23% |
| 2009 FY | 23.83 Thousand USD | -27.94% |
| 2008 Q1 | 6500.00 USD | -16.63% |
| 2008 Q4 | -7050.00 USD | -217.5% |
| 2008 Q3 | 6000.00 USD | -78.28% |
| 2008 FY | 33.07 Thousand USD | -12.49% |
| 2008 Q2 | 27.62 Thousand USD | 325.0% |
| 2007 Q3 | 275.00 USD | 0.0% |
| 2007 Q4 | 7797.00 USD | 2735.27% |
| 2007 FY | 37.79 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -37.024% |
| IR-Med Inc. | 4.89 Million USD | 79.262% |
| Polarean Imaging plc | 12.24 Million USD | 91.71% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 23.142% |
| Avitar, Inc. | 3.56 Million USD | 71.567% |
| AVITA Medical, Inc. | 80.77 Million USD | 98.744% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -44.367% |
| Össur hf. | 396.18 Million USD | 99.744% |
| Zecotek Photonics Inc. | 3.46 Million USD | 70.68% |
| QHSLab, Inc. | 961.65 Thousand USD | -5.537% |
| Wellstar International, Inc. | 1.79 Million USD | 43.45% |
| Össur hf. | 396.18 Million USD | 99.744% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 95.34% |
| Escalon Medical Corp. | 5.25 Million USD | 80.671% |
| Aurora Spine Corporation | 8.65 Million USD | 88.277% |
| BrainsWay Ltd. | 28.01 Million USD | 96.378% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 89.389% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 96.977% |
| Vivos Inc. | 2.78 Million USD | 63.586% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.903% |
| Kelyniam Global, Inc. | 2.27 Million USD | 55.394% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -133.043% |
| Nanomix Corporation | 8.36 Million USD | 87.871% |
| Theraclion SA | 7.43 Million USD | 86.359% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | 21.604% |
| Positron Corporation | 1 Million USD | -0.756% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 67.371% |
| Lombard Medical, Inc. | 30.29 Million USD | 96.649% |
| ALR Technologies Inc. | 6.33 Million USD | 83.982% |
| Stratec SE | 46.32 Million USD | 97.809% |
| Vycor Medical, Inc. | 1.27 Million USD | 20.429% |
| Heart Tronics, Inc. | 14.46 Million USD | 92.981% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -742.061% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -391.671% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 92.828% |
| VMS Rehab Systems, Inc. | 63.63 USD | -1594907.072% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 70.945% |
| Ingen Technologies, Inc. | 1.88 Million USD | 46.079% |
| Odyssey Group International, Inc. | -14.26 Million USD | 107.117% |
| United American Healthcare Corporation | 59 Thousand USD | -1620.175% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -149.065% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -59.906% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 40.144% |
| Urologix, Inc. | 10.09 Million USD | 89.943% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 19.665% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 82.938% |
| SS Innovations International, Inc. | 21.38 Million USD | 95.253% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -340.8% |
| Smith & Nephew plc | 3.46 Billion USD | 99.971% |
| NIOX Group Plc | 22.27 Million USD | 95.444% |
| Fuse Medical, Inc. | 10.35 Million USD | 90.194% |
| Broncus Holding Corporation | 38.15 Million USD | 97.34% |
| Brain Scientific Inc. | 9.66 Million USD | 89.497% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 90.149% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -1572.053% |